| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $708.8M | -0.5% |
| Cost of Revenue | $318.3M | -11.5% |
| Gross Profit | $390.4M | +10.7% |
| R&D Expense | $66.5M | +10.1% |
| SG&A Expense | $68.5M | -6.2% |
| Operating Income | $96.0M | +26.2% |
| Interest Expense | $567K | +73.9% |
| Pre-tax Income | $107.9M | +21.4% |
| Income Tax | $31.2M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $256.2M | +10.4% |
| Short-term Investments | $19.4M | -81.5% |
| Accounts Receivable | $92.0M | -9.8% |
| Inventory | $113.5M | -15.4% |
| Current Assets | $499.6M | -13.9% |
| Total Assets | $580.8M | -16.2% |
| Current Liabilities | $221.1M | +8.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $200.2M | -24.4% |
| Investing Cash Flow | $60.7M | +431.0% |
| Financing Cash Flow | -$237.4M | -51.8% |
| +19.7% |
| Net Income | $76.7M | +22.1% |
| EPS (Basic) | $0.36 | +24.1% |
| EPS (Diluted) | $0.35 | +20.7% |
| Total Liabilities |
| $237.2M |
| +4.8% |
| Stockholders' Equity | $343.6M | -26.4% |